Apremilast(CAS: 608141-41-9)

Apremilast (CAS: 608141-41-9) is a selective phosphodiesterase-4 (PDE4) inhibitor with the chemical formula C19H23NO5S. It is a white to off-white crystalline solid, poorly soluble in water, and exhibits anti-inflammatory properties by modulating cytokine production. Apremilast is primarily used in pharmaceutical applications for treating inflammatory conditions.

Apremilast (CAS: 608141-41-9) is mainly used as a medication for psoriatic arthritis and plaque psoriasis. It works by inhibiting PDE4 enzymes, reducing inflammation and immune response. Additionally, it is utilized in research for studying inflammatory diseases and as a tool compound in drug development.

Apremilast (CAS: 608141-41-9) is generally safe when used as prescribed, with a well-established safety profile in clinical settings. However, it may cause side effects such as gastrointestinal discomfort, headache, or nausea. Proper handling, including use of personal protective equipment, is recommended for laboratory settings. It is approved by regulatory agencies like the FDA for therapeutic use.

Apremilast (CAS: 608141-41-9) should be stored in a cool, dry place, away from direct light, in a sealed container. It maintains stability at controlled room temperature (15-30°C) and is less sensitive to humidity. Always store in a secure location to prevent contamination or accidental exposure.